After conducting research, Universitas Airlangga Covid-19 research team has made progress in an effort to accelerate the Covid-19 handling. The findings are in the form of five combinations of drug regimens derived from drugs that have been available in the market and have potential to be Covid-19 drugs.
With the support of Indonesian State Intelligence Agency (BIN) and some other parties, the drug combinations finding was announced on Friday, June 12, 2020 in Jakarta by Colonel Drs. Bambang Sunarwibowo, SH, M.Hum. Head of Universitas Airlangga Stem Cell Research and Development Center, Dr. dr. Purwati, SpPD, K-PTI FINASIM elaborated the drug combinations:
1. Lopinavir / ritonavir with azithromicyne
2. Lopinavir / ritonavir with doxycyline
3. Lopinavir / ritonavir with chlaritromycine
4. Hydroxychloroquine with azithromicyne
5. Hydroxychloroquine with doxycycline
#UNAIRfightcovid19
#ExcellencewithMorality
#covid19
Негізгі бет UNAIR researchers find five effective drug combinations to fight COVID-19
Пікірлер: 40